Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Sherman

Showing results (31-40 of 367) with videos related to

Pageof 37
Sort By:
Advances in Experimental Medicine and Biology|December 3, 2016
Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic InfluencesAshley S Felix, Hannah P Yang, Daphne W Bell, et al.
Current Obstetrics and Gynecology Reports|December 16, 2014
Emerging Concepts in Breast Cancer Risk PredictionGretchen L Gierach, Xiaohong R Yang, Jonine D Figueroa, et al.
Journal of the National Cancer Institute|January 8, 2004
Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancerRochelle E Curtis, D Michal Freedman, Mark E Sherman, et al.
Journal of the National Cancer Institute|November 17, 2005
Impact of hysterectomy on endometrial carcinoma rates in the United StatesMark E Sherman, Joseph D Carreon, James V Lacey, et al.
Journal of the National Cancer Institute|November 15, 2007
Absolute risk models for subtypes of breast cancerMitchell H Gail, William F Anderson, Montserrat Garcia-Closas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2021
Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk-LetterAmy C Degnim, Derek C Radisky, Celine M Vachon, et al.
Human Pathology|May 23, 2008
Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infectionsMelinda Butsch Kovacic, Hormuzd A Katki, Aimee R Kreimer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2003
Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time biasMark E Sherman, Sophia S Wang, Robert Tarone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Comparison of age distribution patterns for different histopathologic types of breast carcinomaWilliam F Anderson, Ruth M Pfeiffer, Graça M Dores, et al.
International Journal of Cancer|November 26, 2003
Medication use and risk of ovarian carcinoma: a prospective studyJames V Lacey, Mark E Sherman, Patricia Hartge, et al.
Pageof 37

Showing results (31-40 of 367) with videos related to

Sort By:
Pageof 37
Advances in Experimental Medicine and Biology|December 3, 2016
Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic InfluencesAshley S Felix, Hannah P Yang, Daphne W Bell, et al.
Current Obstetrics and Gynecology Reports|December 16, 2014
Emerging Concepts in Breast Cancer Risk PredictionGretchen L Gierach, Xiaohong R Yang, Jonine D Figueroa, et al.
Journal of the National Cancer Institute|January 8, 2004
Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancerRochelle E Curtis, D Michal Freedman, Mark E Sherman, et al.
Journal of the National Cancer Institute|November 17, 2005
Impact of hysterectomy on endometrial carcinoma rates in the United StatesMark E Sherman, Joseph D Carreon, James V Lacey, et al.
Journal of the National Cancer Institute|November 15, 2007
Absolute risk models for subtypes of breast cancerMitchell H Gail, William F Anderson, Montserrat Garcia-Closas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2021
Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk-LetterAmy C Degnim, Derek C Radisky, Celine M Vachon, et al.
Human Pathology|May 23, 2008
Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infectionsMelinda Butsch Kovacic, Hormuzd A Katki, Aimee R Kreimer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2003
Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time biasMark E Sherman, Sophia S Wang, Robert Tarone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Comparison of age distribution patterns for different histopathologic types of breast carcinomaWilliam F Anderson, Ruth M Pfeiffer, Graça M Dores, et al.
International Journal of Cancer|November 26, 2003
Medication use and risk of ovarian carcinoma: a prospective studyJames V Lacey, Mark E Sherman, Patricia Hartge, et al.
Pageof 37